GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sudarshan Pharma Industries Ltd (BOM:543828) » Definitions » ROE %

Sudarshan Pharma Industries (BOM:543828) ROE % : 10.33% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sudarshan Pharma Industries ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sudarshan Pharma Industries's annualized net income for the quarter that ended in Sep. 2024 was ₹118 Mil. Sudarshan Pharma Industries's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was ₹1,147 Mil. Therefore, Sudarshan Pharma Industries's annualized ROE % for the quarter that ended in Sep. 2024 was 10.33%.

The historical rank and industry rank for Sudarshan Pharma Industries's ROE % or its related term are showing as below:

BOM:543828' s ROE % Range Over the Past 10 Years
Min: 4.87   Med: 11.68   Max: 20.08
Current: 11.24

During the past 8 years, Sudarshan Pharma Industries's highest ROE % was 20.08%. The lowest was 4.87%. And the median was 11.68%.

BOM:543828's ROE % is ranked better than
77.23% of 1533 companies
in the Chemicals industry
Industry Median: 4.98 vs BOM:543828: 11.24

Sudarshan Pharma Industries ROE % Historical Data

The historical data trend for Sudarshan Pharma Industries's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sudarshan Pharma Industries ROE % Chart

Sudarshan Pharma Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
Get a 7-Day Free Trial 6.61 12.62 20.08 10.76 10.77

Sudarshan Pharma Industries Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.84 9.02 9.42 12.18 10.33

Competitive Comparison of Sudarshan Pharma Industries's ROE %

For the Chemicals subindustry, Sudarshan Pharma Industries's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sudarshan Pharma Industries's ROE % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's ROE % distribution charts can be found below:

* The bar in red indicates where Sudarshan Pharma Industries's ROE % falls into.


;
;

Sudarshan Pharma Industries ROE % Calculation

Sudarshan Pharma Industries's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=114.553/( (1009.733+1117.066)/ 2 )
=114.553/1063.3995
=10.77 %

Sudarshan Pharma Industries's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Mar. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=118.466/( (1117.066+1176.299)/ 2 )
=118.466/1146.6825
=10.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Sudarshan Pharma Industries  (BOM:543828) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=118.466/1146.6825
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(118.466 / 4555.818)*(4555.818 / 3016.7805)*(3016.7805 / 1146.6825)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.6 %*1.5102*2.6309
=ROA %*Equity Multiplier
=3.93 %*2.6309
=10.33 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=118.466/1146.6825
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (118.466 / 160.498) * (160.498 / 309.136) * (309.136 / 4555.818) * (4555.818 / 3016.7805) * (3016.7805 / 1146.6825)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7381 * 0.5192 * 6.79 % * 1.5102 * 2.6309
=10.33 %

Note: The net income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sudarshan Pharma Industries ROE % Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sudarshan Pharma Industries Business Description

Traded in Other Exchanges
N/A
Address
S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd is engaged in business in Pharmaceutical formulation & Chemical - Bulk drugs, API, Specialty chemicals, and Solvents in India and abroad.

Sudarshan Pharma Industries Headlines

No Headlines